Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,407 | 64,459 | 48,875 | 46,397 | 81,707 |
| Marketable Securities | 297,068 | 255,453 | 301,614 | 291,503 | 269,006 |
| Receivables | 25,522 | 28,909 | 24,089 | 37,946 | 19,499 |
| Inventories | 38,853 | 39,761 | 39,705 | 32,820 | 33,155 |
| Other current assets | 6,976 | 1,995 | 1,031 | 1,645 | 1,208 |
| TOTAL | $409,666 | $398,223 | $424,800 | $426,469 | $415,907 |
| Non-Current Assets | |||||
| PPE Net | 3,043 | 3,198 | 3,354 | 3,496 | 3,650 |
| Investments And Advances | 199 | 199 | 201 | 591 | 0 |
| Intangibles | 4,621 | 4,760 | 4,977 | 5,261 | 5,683 |
| Other Non-Current Assets | 106,000 | 110,254 | 114,730 | 119,196 | 123,660 |
| TOTAL | $113,863 | $118,411 | $123,262 | $128,544 | $132,993 |
| Total Assets | $523,529 | $516,634 | $548,062 | $555,013 | $548,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 56,460 | 50,270 | 4,327 | 52,309 | 41,375 |
| Accrued Expenses | N/A | N/A | 50,062 | N/A | N/A |
| Other current liabilities | 1,162 | 1,150 | 2,388 | 2,611 | 2,088 |
| TOTAL | $76,903 | $71,052 | $77,188 | $73,890 | $61,661 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,367 | 4,909 | 4,813 | 4,662 | 3,228 |
| Other Non-Current Liabilities | 6,146 | 18,631 | 17,441 | 17,053 | 15,525 |
| TOTAL | $82,010 | $86,106 | $92,920 | $89,246 | $94,947 |
| Total Liabilities | $158,913 | $157,158 | $170,108 | $163,136 | $156,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 142,991 | 143,019 | 144,618 | 143,608 | 143,423 |
| Common Shares | 1,205,554 | 1,207,982 | 1,200,218 | 1,198,560 | 1,196,480 |
| Retained earnings | -952,349 | -953,071 | -942,322 | -915,447 | -902,000 |
| Other shareholders' equity | -859 | -854 | -730 | -947 | -1,020 |
| TOTAL | $364,616 | $359,476 | $377,954 | $391,877 | $392,292 |
| Total Liabilities And Equity | $523,529 | $516,634 | $548,062 | $555,013 | $548,900 |